Maytansinoid analogue conjugated to gold nanoparticles inhibits tumor growth in HCC mouse model Jan. 28, 2021
Primary endpoint met in ACTIVATE-T trial of mitapivat in transfused patients with PK deficiency Jan. 27, 2021
RSS